Global Transplantation Therapeutics Market: Industry Analysis & Forecast 2020-2026, By Drug Class, Distribution Channel and Region.

Global Transplantation Therapeutics Market size was valued at USD xx billion in 2019 and is expected to reach US$ 6.3 billion by 2026, at a CAGR of 8.2% during a forecast period.

Global Transplantation Therapeutics Market Overview

Magenta therapeutics successfully completed the final phase 1 result of MGTA -145 for blood and marrow transplantation. This and many other ongoing clinical research activities give the opportunity for the global transplantation therapeutics market. Efforts of the Transplant Therapeutics Consortium, a collaborative venture within the academic transplant community are the drivers of the global market. Medical societies & research organizations offer new educational opportunities to members of the transplant community. That aims to identify unmet medical needs in the field and help spur the development of new transplant drugs.

Global Transplantation Therapeutics Market Segment Analysis

Global Transplantation Therapeutics Market To know about the Research Methodology :- Request Free Sample Report

Antibody Therapies play a significant role in the management of diseases related to cardiac dysfunction.

The involvement of many stockholders, growing research centers for transplant drug evaluation and research are resulting in the outcomes of effective therapeutics to save the lives of patients. Optimization in clinical trial designs and identification of potential therapeutic products commended the largest share XX% of antibody therapeutic segment in the global market. Identification of new biomarkers and birth of Transplantation Therapeutics Consortium (TTC) gives the spectrum of scope research on transplantation therapeutics market.

The involvement of hospital pharmacies indirect patients’ care boost the global transplantation therapeutics market

Innovative research, potential solution to the organ transplant problem increase the sale of transplant therapeutics by hospital pharmacies. The hospital pharmacist is an important patient advocate in the transplant multidisciplinary team and can support patients in their medication to improve medication adherence. Patient information provided by hospital pharmacies and conduction of post-operative self-medication training projected this largest segment share XX% in the global market.

Global Transplantation Therapeutics Market Regional Analysis

                                         Global Transplantation Therapeutics Market Regional Map Global Transplantation Therapeutics Market Regional Analysis  

North America is expected to dominate the Global Transplantation Therapeutics Market during the forecast period.

An increasing number of ongoing transplantation surgeries in North America is witnessing global market growth during the forecast period. The presence of many governments & non-government research organizations, presence of highly recommended National Chemical Laboratories (NCL) are driving the global market in this region. The presence of prominent research parks for transplantation therapeutics and the conduct of Good Manufacturing Practices (GMPs) results in the launch of FDA approved therapeutics in the market.

Global Transplantation Therapeutics Market Report Scope

The objective of the report is to present a comprehensive analysis of the Global Transplantation Therapeutics Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Transplantation Therapeutics Market dynamics, structure by analyzing the market segments and project Global Transplantation Therapeutics Market clear representation of competitive analysis of key players by price, financial position, by detection and equipment portfolio, growth strategies, and regional presence in the Global Transplantation Therapeutics Market make the report investor’s guide.

Global Transplantation Therapeutics Market, Key Highlights:

• Global Transplantation Therapeutics Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Transplantation Therapeutics Market • Global Transplantation Therapeutics Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Global Transplantation Therapeutics Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Global Transplantation Therapeutics Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Transplantation Therapeutics Market are also profiled.

Global Transplantation Therapeutics Market Scope: Inquire before buying

Global Transplantation Therapeutics Market

Global Transplantation Therapeutics Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Global Transplantation Therapeutics Key Players

• Novartis International AG • GlaxoSmithKline Plc • AbbVie Inc • Pfizer Inc • Astellas Pharma Inc • Gilead Sciences Inc • Quark Pharmaceuticals Inc • Takeda Pharmaceutical Company Ltd • Sanofi • Boehringer Ingelheim • Stryker Corp. • Medtronic PLC • 21st Century Medicine • Biolife Solutions • Teva Pharmaceuticals • Veloxis Pharmaceuticals • F. Hoffmann-La Roche Ltd. • Mylan NV • Sun Pharmaceutical Industries Ltd • Cadila Healthcare
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Transplantation Therapeutics Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Transplantation Therapeutics Market 3.4. Geographical Snapshot of the Transplantation Therapeutics Market, By Manufacturer share 4. Global Transplantation Therapeutics Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Transplantation Therapeutics Market 5. Supply Side and Demand Side Indicators 6. Global Transplantation Therapeutics Market Analysis and Forecast, 2019-2026 6.1. Global Transplantation Therapeutics Market Size & Y-o-Y Growth Analysis. 7. Global Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 7.1.1. Antibody Therapies 7.1.2. Calcineurin Inhibitors 7.1.3. Anti-proliferative Agents 7.1.4. mTor Inhibitors 7.1.5. Corticosteroids 7.1.6. Others 7.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 7.2.1. Hospital Pharmacies 7.2.2. Online Pharmacies 7.2.3. Retail Pharmacies 8. Global Transplantation Therapeutics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 9.1.1. Antibody Therapies 9.1.2. Calcineurin Inhibitors 9.1.3. Anti-proliferative Agents 9.1.4. mTor Inhibitors 9.1.5. Corticosteroids 9.1.6. Others 9.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 9.2.1. Hospital Pharmacies 9.2.2. Online Pharmacies 9.2.3. Retail Pharmacies 10. North America Transplantation Therapeutics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 12. Canada Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 13. Mexico Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 14. Europe Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 15. Europe Transplantation Therapeutics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 17. France Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 18. Germany Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 19. Italy Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 20. Spain Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 21. Sweden Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 22. CIS Countries Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 23. Rest of Europe Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 24. Asia Pacific Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 25. Asia Pacific Transplantation Therapeutics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 27. India Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 28. Japan Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 29. South Korea Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 30. Australia Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 31. ASEAN Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 32. Rest of Asia Pacific Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 33. Middle East Africa Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 34. Middle East Africa Transplantation Therapeutics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 36. GCC Countries Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 37. Egypt Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 38. Nigeria Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 39. Rest of ME&A Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 40. South America Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 41. South America Transplantation Therapeutics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 43. Argentina Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 44. Rest of South America Transplantation Therapeutics Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Drug Class, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Distribution Channels, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Transplantation Therapeutics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Medtronic 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Boston Scientific Corporation 45.3.3. GlaxoSmithKline Plc 45.3.4. AbbVie Inc 45.3.5. Pfizer Inc 45.3.6. Astellas Pharma Inc 45.3.7. Gilead Sciences Inc 45.3.8. Quark Pharmaceuticals Inc 45.3.9. Takeda Pharmaceutical Company Ltd 45.3.10. Sanofi 45.3.11. Boehringer Ingelheim 45.3.12. Stryker Corp. 45.3.13. Medtronic PLC 45.3.14. 21st Century Medicine 45.3.15. Biolife Solutions 45.3.16. Teva Pharmaceuticals 45.3.17. Veloxis Pharmaceuticals 45.3.18. F. Hoffmann-La Roche Ltd. 45.3.19. Mylan NV 45.3.20. Sun Pharmaceutical Industries Ltd 45.3.21. Cadila Healthcare 46. Primary Key Insights

About This Report

Report ID 95404
Category Healthcare
Published Date April 2021
Updated Date
Contact Us